eResearch Technology

eResearch Technology, also known as ERT, is a technology firm that specializes in providing solutions for clinical trial services. Its core offerings support the planning, execution, and management of research studies, primarily serving pharmaceutical companies, biotechnology firms, and academic research organizations. The company’s technology enables electronic capture and handling of trial data, helping sponsors streamline study workflows and maintain data integrity across diverse therapeutic areas.

The organisation is headquartered in the United States of America, as indicated in the available profile details. While specific figures regarding employee count, revenue, or global footprint are not disclosed in the source material, the company’s involvement in high‑profile COVID‑19 vaccine and treatment research illustrates its reach within the life sciences sector. This participation underscores its role as a service provider to entities engaged in critical public‑health initiatives.

A distinguishing attribute of eResearch Technology is its focus on supporting clinical trials that require rigorous data management and regulatory compliance, as evidenced by the ransomware incident of September 20 2020. The attack disrupted electronic systems used by trial researchers, forcing a temporary shift to manual data recording, yet the company’s pre‑existing backups prevented data loss and allowed containment and restoration without yielding to ransom demands. This event highlights the firm’s importance to vaccine development pipelines and its capacity to maintain operational resilience under cyber‑threat pressure.

No explicit information about ownership, parent‑company relationships, or subsidiary status is provided in the source material, so such structural details remain unspecified based on the available facts.